These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34094645)

  • 1. CD36 Signaling in Diabetic Cardiomyopathy.
    Zhang X; Fan J; Li H; Chen C; Wang Y
    Aging Dis; 2021 Jun; 12(3):826-840. PubMed ID: 34094645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction.
    Glatz JFC; Luiken JJFP; Nabben M
    J Lipid Atheroscler; 2020 Jan; 9(1):66-78. PubMed ID: 32821722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 tango in cancer: signaling pathways and functions.
    Wang J; Li Y
    Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR α/γ activity in microvascular endothelial cells.
    Madonna R; Salerni S; Schiavone D; Glatz JF; Geng YJ; De Caterina R
    Thromb Haemost; 2011 Sep; 106(3):500-10. PubMed ID: 21727988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding.
    Jay AG; Chen AN; Paz MA; Hung JP; Hamilton JA
    J Biol Chem; 2015 Feb; 290(8):4590-4603. PubMed ID: 25555908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
    Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
    J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins.
    Kunjathoor VV; Tseng AA; Medeiros LA; Khan T; Moore KJ
    J Neuroinflammation; 2004 Nov; 1(1):23. PubMed ID: 15546489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.
    Silverstein RL; Febbraio M
    Sci Signal; 2009 May; 2(72):re3. PubMed ID: 19471024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products.
    Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
    J Biol Chem; 2001 Feb; 276(5):3195-202. PubMed ID: 11035013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.
    Ren B; Best B; Ramakrishnan DP; Walcott BP; Storz P; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1197-208. PubMed ID: 27013613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Past and Present Lives of the Intraocular Transmembrane Protein CD36.
    Yang R; Liu Q; Zhang M
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD36 deficiency rescues lipotoxic cardiomyopathy.
    Yang J; Sambandam N; Han X; Gross RW; Courtois M; Kovacs A; Febbraio M; Finck BN; Kelly DP
    Circ Res; 2007 Apr; 100(8):1208-17. PubMed ID: 17363697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.
    Zeng Y; Tao N; Chung KN; Heuser JE; Lublin DM
    J Biol Chem; 2003 Nov; 278(46):45931-6. PubMed ID: 12947091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes.
    Angin Y; Steinbusch LK; Simons PJ; Greulich S; Hoebers NT; Douma K; van Zandvoort MA; Coumans WA; Wijnen W; Diamant M; Ouwens DM; Glatz JF; Luiken JJ
    Biochem J; 2012 Nov; 448(1):43-53. PubMed ID: 22780108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein.
    Boullier A; Gillotte KL; Hörkkö S; Green SR; Friedman P; Dennis EA; Witztum JL; Steinberg D; Quehenberger O
    J Biol Chem; 2000 Mar; 275(13):9163-9. PubMed ID: 10734051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36.
    Enenstein J; Gupta K; Vercellotti GM; Hebbel RP
    Exp Cell Res; 1998 Feb; 238(2):465-71. PubMed ID: 9473355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD36 in chronic kidney disease: novel insights and therapeutic opportunities.
    Yang X; Okamura DM; Lu X; Chen Y; Moorhead J; Varghese Z; Ruan XZ
    Nat Rev Nephrol; 2017 Dec; 13(12):769-781. PubMed ID: 28919632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
    Wintergerst ES; Jelk J; Rahner C; Asmis R
    Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications.
    Tian K; Xu Y; Sahebkar A; Xu S
    Curr Atheroscler Rep; 2020 Aug; 22(10):59. PubMed ID: 32772254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.